Episode 121 - Tirzepatide vs. Semaglutide for Obesity

Episode 121 - Tirzepatide vs. Semaglutide for Obesity

Published on Jun 5
473
The Rounds Table
0:00
0:00
<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1743909/open_sms">Send us a text</a></p><p>Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recently published head-to-head trial exploring the safety and efficacy of tirzepatide compared to semaglutide for obesity management. Here we go!</p><ol><li><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2416394'>Tirzepatide as Compared with Semaglutide for the Treatment of Obesity</a> (0:00 – 7:07).</li></ol><p>The Good Stuff:</p><ul><li><a href='https://trialfiles.substack.com/'>Trial Files</a>, a free monthly newsletter on practice-changing trials, delivered straight to your inbox. (7:08 - 7:53)</li></ul><p>Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods</p>
Episode 121 - Tirzepatide vs. Semaglutide for Obesity - The Rounds Table - 播刻岛